BXRX
Baudax Bio, Inc. Common Stock
BXRX
BXRX
Delisted
BXRX was delisted on the 15th of November, 2023.
38 hedge funds and large institutions have $18.1M invested in Baudax Bio, Inc. Common Stock in 2020 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 5 increasing their positions, 16 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
69% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 16
Holders
38
Holding in Top 10
1
Calls
$4.14M
Puts
$363K
Top Buyers
| 1 | +$1.09M | |
| 2 | +$950K | |
| 3 | +$677K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$283K |
| 5 |
OAM
Oberweis Asset Management
Lisle,
Illinois
|
+$268K |
Top Sellers
| 1 | -$1.51M | |
| 2 | -$1.37M | |
| 3 | -$1.07M | |
| 4 |
Alyeska Investment Group
Chicago,
Illinois
|
-$992K |
| 5 |
SM
Sabby Management
Miami Beach,
Florida
|
-$927K |